| HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression … RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ... The Lancet infectious diseases 18 (3), 346-355, 2018 | 425 | 2018 |
| Genomic-informed pathogen surveillance in Africa: opportunities and challenges SC Inzaule, SK Tessema, Y Kebede, AEO Ouma, JN Nkengasong The Lancet Infectious Diseases 21 (9), e281-e289, 2021 | 148 | 2021 |
| Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya C Zeh, PN Amornkul, S Inzaule, P Ondoa, B Oyaro, DM Mwaengo, ... PLOS one 6 (6), e21040, 2011 | 104 | 2011 |
| Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis RS Boerma, KCE Sigaloff, AS Akanmu, S Inzaule, ... Journal of Antimicrobial Chemotherapy 72 (2), 365-371, 2017 | 92 | 2017 |
| Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study SC Inzaule, RL Hamers, C Kityo, TF Rinke de Wit, M Roura PloS one 11 (11), e0167492, 2016 | 89 | 2016 |
| Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa SC Inzaule, P Ondoa, T Peter, PN Mugyenyi, WS Stevens, TFR de Wit, ... The Lancet Infectious Diseases 16 (11), e267-e275, 2016 | 84 | 2016 |
| Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study SC Inzaule, RL Hamers, M Noguera-Julian, M Casadellà, M Parera, ... The Lancet HIV 5 (11), e638-e646, 2018 | 70 | 2018 |
| Field experience in implementing ISO 15189 in Kisumu, Kenya CE Zeh, SC Inzaule, VO Magero, TK Thomas, KF Laserson, CE Hart, ... American journal of clinical pathology 134 (3), 410-418, 2010 | 70 | 2010 |
| Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa SC Inzaule, RL Hamers, M Noguera-Julian, M Casadellà, M Parera, ... Journal of Antimicrobial Chemotherapy 73 (5), 1167-1172, 2018 | 64 | 2018 |
| COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control SC Inzaule, P Ondoa, MM Loembe, YK Tebeje, AEO Ouma, ... PLoS Medicine 18 (6), e1003666, 2021 | 63 | 2021 |
| Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens SC Inzaule, RL Hamers, M Doherty, RW Shafer, S Bertagnolio, ... The Lancet Infectious diseases 19 (7), e246-e252, 2019 | 55 | 2019 |
| Incidence and predictors of first line antiretroviral regimen modification in western Kenya S Inzaule, J Otieno, J Kalyango, L Nafisa, C Kabugo, J Nalusiba, D Kwaro, ... PloS one 9 (4), e93106, 2014 | 50 | 2014 |
| Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact HA Mbunkah, S Bertagnolio, RL Hamers, G Hunt, S Inzaule, ... The Journal of infectious diseases 221 (10), 1584-1597, 2020 | 49 | 2020 |
| Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor–containing antiretroviral … S Bertagnolio, L Hermans, MR Jordan, S Avila-Rios, C Iwuji, A Derache, ... The Journal of Infectious Diseases 224 (3), 377-388, 2021 | 46 | 2021 |
| Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country S Inzaule, C Yang, A Kasembeli, L Nafisa, J Okonji, B Oyaro, R Lando, ... Journal of clinical microbiology 51 (2), 529-539, 2013 | 44 | 2013 |
| Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in … C Zeh, K Ndiege, S Inzaule, R Achieng, J Williamson, J Chih-Wei Chang, ... PloS one 12 (6), e0179316, 2017 | 41 | 2017 |
| Prevalence, incidence and correlates of HSV-2 infection in an HIV incidence adolescent and adult cohort study in western Kenya B Akinyi, C Odhiambo, F Otieno, S Inzaule, S Oswago, E Kerubo, R Ndivo, ... PLoS One 12 (6), e0178907, 2017 | 39 | 2017 |
| Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya H Onywera, D Maman, S Inzaule, E Auma, K Were, H Fredrick, P Owiti, ... PloS one 12 (2), e0171124, 2017 | 38 | 2017 |
| Accelerating genomics-based surveillance for COVID-19 response in Africa SK Tessema, SC Inzaule, A Christoffels, Y Kebede, T de Oliveira, ... The Lancet Microbe 1 (6), e227-e228, 2020 | 35 | 2020 |
| The evolving landscape of HIV drug resistance diagnostics for expanding testing in resource-limited settings SC Inzaule, RL Hamers, R Paredes, C Yang, R Schuurman, ... AIDS Rev 19 (4), 219-30, 2017 | 33 | 2017 |
